SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
8-K	Report of unscheduled material events or corporate event	Mar 04, 2021	View HTML 0001564590-21-010712.pdf 0001564590-21-010712.rtf 0001564590-21-010712.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K	Annual report which provides a comprehensive overview of the company for the past year	Mar 12, 2021	View HTML 0001564590-21-012894.pdf 0001564590-21-012894.rtf 0001564590-21-012894.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
DEFA14A	Additional proxy soliciting materials - definitive	Apr 30, 2021	View HTML 0001564590-21-022617.pdf 0001564590-21-022617.rtf 0001564590-21-022617.xls
DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	May 03, 2021	View HTML 0001564590-21-022639.pdf 0001564590-21-022639.rtf 0001564590-21-022639.xls
NT 10-K	Notification that form 10-K will be submitted late	May 03, 2021	View HTML 0001193125-21-146673.pdf 0001193125-21-146673.rtf 0001193125-21-146673.xls
10-K/A	Amendment to a previously filed 10-K	May 04, 2021	View HTML 0001193125-21-149160.pdf 0001193125-21-149160.rtf 0001193125-21-149160.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-K	Report of unscheduled material events or corporate event	May 05, 2021	View HTML 0001564590-21-023625.pdf 0001564590-21-023625.rtf 0001564590-21-023625.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-Q	Quarterly report which provides a continuing view of a company's financial position	May 05, 2021	View HTML 0001564590-21-023626.pdf 0001564590-21-023626.rtf 0001564590-21-023626.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
S-3/A	Pre-effective amendment to an S-3 filing	May 05, 2021	View HTML 0001193125-21-151688.pdf 0001193125-21-151688.rtf 0001193125-21-151688.xls
CORRESP	CORRESP	May 05, 2021	View HTML 0001193125-21-151701.pdf 0001193125-21-151701.rtf 0001193125-21-151701.xls

Data provided by Kaleidoscope.